Yale School of Medicine
New Haven, Connecticut, 06510, United States
NCT Number: NCT05495997
The purpose of this research study is to determine whether cognitive training will improve cognitive and brain functions in people with Parkinson's Disease (PD) during activities of daily living using cognitive evaluations and magnetic resonance imaging (MRI).
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
New Haven, Connecticut, 06510, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will practice mental imagery of everyday tasks daily for 6 weeks.
Participants will receive psychoeducation on cognition and brain health.
Time frame: Baseline and 6 weeks
Neuro-QoL CF v2 measures self-reported levels of cognitive functioning. Raw scores are converted to standardized T-scores (mean of 50 with a standard deviation of 10). Increase in T-scores from baseline indicates improvement in everyday cognitive functioning.
Time frame: 18 weeks
Neuro-QoL CF v2 measures self-reported levels of cognitive functioning. Raw scores are converted to standardized T-scores (mean of 50 with a standard deviation of 10). Increase in T-scores from baseline indicates improvement in everyday cognitive functioning.
Time frame: 6 weeks
T-scores (mean of 50 with a standard deviation of 10) of executive function tests (i.e., Stroop, F-A-S letter fluency, and Trail Making B tests) were averaged to obtain a composite executive function score for each subject. Higher scores indicate better executive function.
Time frame: 18 weeks
T-scores (mean of 50 with a standard deviation of 10) of executive function tests (i.e., Stroop, F-A-S letter fluency, and Trail Making B tests) were averaged to obtain a composite executive function score for each subject. Higher scores indicate better executive function.
Yale University
Other
Effects of Cognitive Training on Everyday Cognitive and Brain Function in Parkinson's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06690931
Basal Ganglia Diseases, Brain Diseases
Schiedlberg, Upper Austria, Austria
View Trial DetailsNCT05511597
Basal Ganglia Diseases, Brain Diseases
Leuven, Belgium
View Trial DetailsNCT03811405
Basal Ganglia Diseases, Brain Diseases
Gainesville, Florida, United States
View Trial DetailsNCT04932434
Anxiety, Anxiety Disorders
San Francisco, California, United States
View Trial Details